-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Cut to $470.00/Share From $510.00 by HC Wainwright & Co.

Dow Jones·06/29/2026 10:21:00

Please log in to view news